Anixa Biosciences's market cap is currently $102.06M. The company's EPS TTM is $-0.393; its P/E ratio is ―; Anixa Biosciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Income Statement
Total Revenue	$ 0.00	$ 210.00K	$ 2.47B	$ 512.50K	$ 0.00
Gross Profit	$ 0.00	$ 49.00K	$ 2.47B	$ 127.50K	$ -90.16K
Operating Income	$ -13.83M	$ -11.01M	$ -13.88M	$ -13.14M	$ -9.98M
EBITDA	$ -13.83M	$ -10.96M	$ -13.73M	$ -13.08M	$ -10.00M
Net Income	$ -12.55M	$ -9.81M	$ -13.49M	$ -12.95M	$ -10.13M
Balance Sheet
Cash & Short-Term Investments	$ 19.92M	$ 23.84M	$ 29.69M	$ 35.73M	$ 9.06M
Total Assets	$ 21.59M	$ 25.52M	$ 30.41M	$ 36.26M	$ 9.45M
Total Debt	$ 232.00K	$ 175.00K	$ 221.00K	$ 259.48K	$ 55.20K
Net Debt	$ -1.04M	$ -740.00K	$ -12.14M	$ -28.87M	$ -6.36M
Total Liabilities	$ 2.70M	$ 2.15M	$ 2.21M	$ 1.49M	$ 1.19M
Stockholders' Equity	$ 20.00M	$ 24.34M	$ 29.05M	$ 35.44M	$ 8.76M
Cash Flow
Free Cash Flow	$ -7.33M	$ -6.21M	$ -6.49M	$ -4.94M	$ -6.19M
Operating Cash Flow	$ -7.33M	$ -6.21M	$ -6.49M	$ -4.94M	$ -6.18M
Investing Cash Flow	$ 4.28M	$ -5.60M	$ -10.73M	$ -3.92M	$ -305.79K
Financing Cash Flow	$ 3.42M	$ 366.00K	$ 452.00K	$ 31.57M	$ 9.41M

Currency in USD

Anixa Biosciences Earnings and Revenue History

Income Statement >

Anixa Biosciences Debt to Assets

Balance Sheet >

Anixa Biosciences Cash Flow

Cash Flow >

Anixa Biosciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing